U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IBI 322 [WHO-DD]
Preferred Name English
SIMRIDARLIMAB
INN  
Official Name English
simridarlimab [INN]
Common Name English
IMMUNOGLOBULIN G (298-ALANINE,299-ALANINE,413-CYSTEINE,430-SERINE,432-ALANINE,471-VALINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMANIZED CAMELUSBACTRIANUS MONOCLONAL BI127 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GSSS)4 FUSION
Common Name English
Code System Code Type Description
NCI_THESAURUS
C176744
Created by admin on Wed Apr 02 06:17:32 GMT 2025 , Edited by admin on Wed Apr 02 06:17:32 GMT 2025
PRIMARY
INN
11730
Created by admin on Wed Apr 02 06:17:32 GMT 2025 , Edited by admin on Wed Apr 02 06:17:32 GMT 2025
PRIMARY
SMS_ID
300000042099
Created by admin on Wed Apr 02 06:17:32 GMT 2025 , Edited by admin on Wed Apr 02 06:17:32 GMT 2025
PRIMARY
CAS
2378862-90-7
Created by admin on Wed Apr 02 06:17:32 GMT 2025 , Edited by admin on Wed Apr 02 06:17:32 GMT 2025
PRIMARY
FDA UNII
0VN2H61ATB
Created by admin on Wed Apr 02 06:17:32 GMT 2025 , Edited by admin on Wed Apr 02 06:17:32 GMT 2025
PRIMARY
ACTIVE MOIETY
SIMRIDARLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966